[HTML][HTML] Purinergic signalling: therapeutic developments

G Burnstock - Frontiers in pharmacology, 2017 - frontiersin.org
Purinergic signalling, ie, the role of nucleotides as extracellular signalling molecules, was
proposed in 1972. However, this concept was not well accepted until the early 1990's when …

Targeting mycobacterial membranes and membrane proteins: Progress and limitations

G Kumar, S Kapoor - Bioorganic & medicinal chemistry, 2023 - Elsevier
Among the various bacterial infections, tuberculosis continues to hold center stage. Its
causative agent, Mycobacterium tuberculosis, possesses robust defense mechanisms …

Targeting Phenotypically Tolerant Mycobacterium tuberculosis

B Gold, C Nathan - Tuberculosis and the Tubercle Bacillus, 2017 - Wiley Online Library
Two parallel revolutions were born in the golden era of antibiotics (~ 1940 to 1960). One
was a revolution in medicine as physicians went to war with microbes. The second was a …

[HTML][HTML] An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis

K Hards, CY Cheung, N Waller, C Adolph… - Communications …, 2022 - nature.com
Increasing antimicrobial resistance compels the search for next-generation inhibitors with
differing or multiple molecular targets. In this regard, energy conservation in Mycobacterium …

[HTML][HTML] Structural simplification: an efficient strategy in lead optimization

S Wang, G Dong, C Sheng - Acta Pharmaceutica Sinica B, 2019 - Elsevier
The trend toward designing large hydrophobic molecules for lead optimization is often
associated with poor drug-likeness and high attrition rates in drug discovery and …

Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions

GM Cook, K Hards, E Dunn, A Heikal… - Tuberculosis and the …, 2017 - Wiley Online Library
The genus Mycobacterium comprises a group of obligately aerobic bacteria that have
adapted to inhabit a wide range of intracellular and extracellular environments …

Recent advances in biological active sulfonamide based hybrid compounds Part A: Two-component sulfonamide hybrids

R Ghomashi, S Ghomashi, H Aghaei… - Current Medicinal …, 2023 - ingentaconnect.com
Sulfonamides constitute an important class of drugs, with many types of pharmacological
agents possessing antibacterial, anti-carbonic anhydrase, anti-obesity, diuretic …

Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis

M Urban, V Šlachtová, L Brulikova - European Journal of Medicinal …, 2021 - Elsevier
Causing approximately 10 million incident cases and 1.3–1.5 million deaths every year,
Mycobacterium tuberculosis remains a global health problem. The risk is further …

Manganese‐Catalysed Deuterium Labelling of Anilines and Electron‐Rich (Hetero) Arenes

F Bourriquen, N Rockstroh, S Bartling… - Angewandte Chemie …, 2022 - Wiley Online Library
There is a constant need for deuterium‐labelled products for multiple applications in life
sciences and beyond. Here, a new class of heterogeneous catalysts is reported for practical …

Deletion of a unique loop in the mycobacterial F‐ATP synthase γ subunit sheds light on its inhibitory role in ATP hydrolysis‐driven H+ pumping

A Hotra, M Suter, G Biuković, P Ragunathan… - The FEBS …, 2016 - Wiley Online Library
The F1 FO‐ATP synthase is one of the enzymes that is essential to meet the energy
requirement of both the proliferating aerobic and hypoxic dormant stages of the life cycle of …